JP Morgan Chase’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.56M	Buy	415,655 +136,150	+49%	+$1.18M	﹤0.01%	3633
2025 Q4	$2.1M	Sell	279,505 -234,010	-46%	-$2.37M	﹤0.01%	4026
2025 Q3	$4.46M	Sell	513,515 -374,501	-42%	-$2.24M	﹤0.01%	3462
2025 Q2	$3.29M	Buy	888,016 +1,311	+0.1%	+$4.61K	﹤0.01%	3522
2025 Q1	$2.86M	Buy	886,705 +66,636	+8%	+$314K	﹤0.01%	3597
2024 Q4	$4.57M	Buy	820,069 +504,086	+160%	+$3.96M	﹤0.01%	3438
2024 Q3	$3.42M	Sell	315,983 -29,790	-9%	-$494K	﹤0.01%	3525
2024 Q2	$7.26M	Sell	345,773 -56,768	-14%	-$1.42M	﹤0.01%	2746
2024 Q1	$12.8M	Sell	402,541 -25,849	-6%	-$659K	﹤0.01%	2261
2023 Q4	$8.68M	Sell	428,390 -157,061	-27%	-$2.07M	﹤0.01%	2610
2023 Q3	$7.45M	Buy	585,451 +128,237	+28%	+$2.14M	﹤0.01%	2518
2023 Q2	$8.26M	Buy	457,214 +16,901	+4%	+$311K	﹤0.01%	2458
2023 Q1	$7.57M	Buy	440,313 +339	+0.1%	+$6.59K	﹤0.01%	2514
2022 Q4	$9.77M	Sell	439,974 -13,134	-3%	-$203K	﹤0.01%	2277
2022 Q3	$3.64M	Sell	453,108 -25,649	-5%	-$232K	﹤0.01%	3002
2022 Q2	$3.34M	Buy	478,757 +111,212	+30%	+$1.08M	﹤0.01%	3132
2022 Q1	$5.56M	Buy	367,545 +84,158	+30%	+$1.32M	﹤0.01%	2927
2021 Q4	$6.22M	Buy	283,387 +53,451	+23%	+$1.31M	﹤0.01%	2866
2021 Q3	$6.2M	Buy	229,936 +216,850	+1,657%	+$6.18M	﹤0.01%	2857
2021 Q2	$316K	Sell	13,086 -7,785	-37%	-$238K	﹤0.01%	4977
2021 Q1	$905K	Buy	+20,871	New	+$924K	﹤0.01%	4304